The Corporate Counsel: March-April 2020

• A Disclosure Framework for the Coronavirus
• The SEC Weighs In
• Coronavirus Disclosure Considerations
• Executives in Trouble: Is Disclosure of Uncharged Conduct Required?
• Other Potential Disclosure Considerations
• "Test the Waters for All" Means WKSIs, Too!
• What WKSIs Can Do Under Rule 163
• The "Test the Waters" Rule 163B Alternative
• Mix & Match? Rule 163B is Non-Exclusive
• Conclusion: WKSIs Should Keep Rule 163B in Mind
• It's Here: 2020 Executive Compensation Disclosure Treatise
• Early Bird Registration! Our "Proxy Disclosure/Executive Pay Conferences"

The Corporate Executive: January-February 2020

• It is All Relative: A Roadmap for Using Relative Total Shareholder Return
• Types of RTSR Plans
• Peer Group Members
• Selecting the Performance Measurement Period
• Vesting Criteria
• Defining Key Terms and Provisions
• Financial Accounting Considerations
• Portfolio Theory and Long-Term Incentives
• SEC Proposes Rules on Proxy Advisory Firms
• SEC Provides "Interpretive Guidance"
• ISS Files a Lawsuit
• Proposed Rules
• 2020 Executive Compensation Treatise
• Early Bird Registration: Our "Proxy Disclosure/Executive Pay Conferences"

The Corporate Counsel: January-February 2020

• Annual Season Items
• Time for a Risk Factor Tune-Up?
• Getting Back to Basics
• Rooting Out Hypothetical Risk Factor Disclosure
• Brexit—What's Next?
• LIBOR Transition
• IP and Technology Risks Associated with International Business Operations
• Tariffs and Trade
• World Health Concerns
• Data Privacy
• Omitting Third Year Comparisons from MD&A: The Staff Weighs In
• More on MD&A: The Commission's Interpretive Release on KPIs and Metrics
• A Brave New World for Confidential Treatment: Asking for Forgiveness Instead of Permission
• A New Streamlined Confidential Treatment Process Dawns
• Self-Executing Rules
• Staff Review of Exhibits
• New Streamlined Extension Confidential Treatment Request Procedures
• Enter the Supremes: The Impact of Argus Leader
• The SEC's New Confidential Treatment Request Guidance
• 2020 Executive Compensation Disclosure Treatise
• Early Bird Registration: Our "Proxy Disclosure/Executive Pay Conferences"

The Corporate Executive: November-December 2019

• Is it Time to Adopt a Perquisites Policy?
• Will They Know a Perquisite When They See It?
• Is the Perquisite Authorized?
• How is a Perquisite Valued?
• What is the Purpose of the Perquisite?
• What Must be Disclosed about Perquisites?
• Drafting and Adopting the Perquisites Policy
• Rolling Out the Perquisites Policy
• Making the Grade: Is Your CD&A Still Doing its Job?
• Getting Back to Basics: A Focus on the "A" in CD&A
• Is a Summary of the Summary Really Necessary?
• A Picture is Worth a Thousand Words
• Don't Lose Sight of the "Voluntary" Disclosures
• Relying on Disclosure Outside of CD&A
• Is Your CD&A Staffing Right?
• The Spotlight is on Non-GAAP Financial Measures of Performance
• CII's Objections
• Commissioner Jackson's Views
• What Now?
• Revisiting the SEC's Compensation Risk Disclosure Rule 10 Years Later
• The Item 402(s) Disclosure Requirement: Rule vs. Practice
• ISS FAQs as to Compensation Policies for 2020
• Quantitative Pay-for-Performance Screens
• Equity Plan Scorecard
• Excessive Director Pay
• Disclosure of Termination & Severance Payments
• 2020 Executive Compensation Disclosure Treatise
• 2020 Edition of "Proxy Season Disclosure Treatise"

The Corporate Counsel - Choose year: Select Year... 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1975-1976
or Browse List of Issues

The Corporate Executive - Choose year: Select Year... 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1986 - 1987
or Browse List of Issues